The Pritzker Organization Invests in Systems Oncology (Series B)

October 22, 2019

Pritzker Family Business Interests, advised by The Pritzker Organization, participated in the first closing of Systems Oncology's Series B financing. The growth capital will fund discovery research and pre-clinical development of Systems Oncology's AI-driven cancer therapeutics platform, and TPO will take a board seat.

Buyers
The Pritzker Organization, Pritzker Family Business Interests (advised by The Pritzker Organization)
Targets
Systems Oncology, LLC
Industry
Biotechnology
Location
Arizona, United States
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.